ECG

Value 20242025 TTM Total revenue 2.85 B3.75 B 3.75 B Gross profit 339.45 M454.09 M 454.09 M Operating expenses 144.27 M184.11 M 184.41 M Selling/general/admin expenses 149.54 M189.34 M 189.34 M Research & development —— — Operating income 189.91 M264.75 M 264.75 M Non-Operating Income, Total 4.88 M15.28 M 6.19 M Interest expense, net of interest capitalized 14.02 M21.45 M 21.45 M Non-Operating Income, excl. Interest Expenses -9.15 M-16.11 M -15.26 M Unusual income/expense —9.94 M — Pretax income 192.94 M274.08 M 274.08 M Equity in earnings 12.19 M16.27 M 16.27 M Taxes 49.52 M72.31 M 72.31 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 143.42 M201.77 M 201.77 M Discontinued operations —— — Net income 143.42 M201.77 M 201.77 M Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 143.42 M201.77 M 201.77 M Basic earnings per share (Basic EPS) 2.813.95 3.95 Diluted earnings per share (Diluted EPS) 2.813.95 3.95 Average basic shares outstanding 50.97 M51.05 M 204.18 M Diluted shares outstanding 51.07 M51.12 M 204.44 M EBITDA 220.75 M300.35 M 300.35 M EBIT 195.18 M269.97 M 269.67 M Cost of revenue 2.51 B3.29 B 3.29 B Other cost of goods sold —— — Depreciation & amortization (cash flow) 25.56 M30.38 M 30.68 M